Banks - Regional
Build Your Comparison
Side-by-side financial analysisStock Comparison
PROV vs BSVN vs JPM vs HOMB vs V
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Diversified
Banks - Regional
Financial - Credit Services
PROV vs BSVN vs JPM vs HOMB vs V — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Diversified | Banks - Regional | Financial - Credit Services |
| Market Cap | $109M | $446M | $896.00B | $5.58B | $618.49B |
| Revenue (TTM) | $60M | $137M | $280.33B | $1.37B | $43.03B |
| Net Income (TTM) | $7M | $43M | $57.05B | $475M | $22.24B |
| Gross Margin | 67.8% | 69.7% | 60.0% | 77.3% | 81.3% |
| Operating Margin | 16.2% | 41.4% | 25.9% | 43.8% | 61.1% |
| Forward P/E | 15.4x | 10.5x | 14.4x | 11.5x | 24.5x |
| Total Debt | $213M | $0.00 | $942.38B | $935M | $25.17B |
| Cash & Equiv. | $53M | $245M | $343.34B | $667M | $20.15B |
PROV vs BSVN vs JPM vs HOMB vs V — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Provident Financial… (PROV) | 100 | 127.6 | +27.6% |
| Bank7 Corp. (BSVN) | 100 | 428.0 | +328.0% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
| Home Bancshares, In… (HOMB) | 100 | 183.7 | +83.7% |
| Visa Inc. (V) | 100 | 166.9 | +66.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PROV vs BSVN vs JPM vs HOMB vs V
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PROV is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 0 yrs, beta 0.21, yield 3.3%
- Beta 0.21, yield 3.3%, current ratio 0.06x
- Beta 0.21 vs JPM's 0.94, lower leverage
- 3.3% yield, vs V's 0.7%
BSVN ranks third and is worth considering specifically for valuation efficiency and bank quality.
- PEG 0.61 vs V's 1.55
- NIM 4.5% vs JPM's 2.2%
- Lower P/E (10.5x vs 24.5x), PEG 0.61 vs 1.55
JPM is the clearest fit if your priority is long-term compounding.
- 465.8% 10Y total return vs BSVN's 169.2%
- +21.8% vs V's -12.5%
Among these 5 stocks, HOMB doesn't own a clear edge in any measured category.
V carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 11.3%, EPS growth 4.8%
- Lower volatility, beta 0.54, Low D/E 66.4%, current ratio 1.08x
- 11.3% NII/revenue growth vs HOMB's -5.3%
- Efficiency ratio 0.2% vs PROV's 0.5% (lower = leaner)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.3% NII/revenue growth vs HOMB's -5.3% | |
| Value | Lower P/E (10.5x vs 24.5x), PEG 0.61 vs 1.55 | |
| Quality / Margins | Efficiency ratio 0.2% vs PROV's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.21 vs JPM's 0.94, lower leverage | |
| Dividends | 3.3% yield, vs V's 0.7% | |
| Momentum (1Y) | +21.8% vs V's -12.5% | |
| Efficiency (ROA) | Efficiency ratio 0.2% vs PROV's 0.5% |
PROV vs BSVN vs JPM vs HOMB vs V — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
PROV vs BSVN vs JPM vs HOMB vs V — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
V leads in 2 of 6 categories
BSVN leads 1 • JPM leads 1 • PROV leads 1 • HOMB leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
V leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 4661.3x PROV's $60M. V is the more profitable business, keeping 51.7% of every revenue dollar as net income compared to PROV's 11.0%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $60M | $137M | $280.3B | $1.4B | $43.0B |
| EBITDAEarnings before interest/tax | $12M | $58M | $81.4B | $618M | $27.6B |
| Net IncomeAfter-tax profit | $7M | $43M | $57.0B | $475M | $22.2B |
| Free Cash FlowCash after capex | $9M | $36M | $100.9B | $311M | $21.2B |
| Gross MarginGross profit ÷ Revenue | +67.8% | +69.7% | +60.0% | +77.3% | +81.3% |
| Operating MarginEBIT ÷ Revenue | +16.2% | +41.4% | +25.9% | +43.8% | +61.1% |
| Net MarginNet income ÷ Revenue | +11.0% | +31.4% | +20.4% | +34.6% | +51.7% |
| FCF MarginFCF ÷ Revenue | +15.3% | +26.4% | +36.0% | +22.6% | +49.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +69.2% | -3.4% | +16.0% | +26.0% | +35.3% |
Valuation Metrics
BSVN leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 10.3x trailing earnings, BSVN trades at a 67% valuation discount to V's 31.6x P/E. Adjusting for growth (PEG ratio), BSVN offers better value at 0.61x vs V's 2.00x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $109M | $446M | $896.0B | $5.6B | $618.5B |
| Enterprise ValueMkt cap + debt − cash | $269M | $202M | $1.50T | $5.9B | $623.5B |
| Trailing P/EPrice ÷ TTM EPS | 18.40x | 10.33x | 16.00x | 11.72x | 31.61x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.41x | 10.46x | 14.40x | 11.47x | 24.51x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.61x | 0.90x | 0.89x | 2.00x |
| EV / EBITDAEnterprise value multiple | 21.77x | 3.48x | 18.36x | 9.47x | 24.73x |
| Price / SalesMarket cap ÷ Revenue | 1.81x | 3.25x | 3.20x | 4.06x | 15.46x |
| Price / BookPrice ÷ Book value/share | 0.90x | 1.77x | 2.47x | 1.30x | 16.72x |
| Price / FCFMarket cap ÷ FCF | 13.38x | 10.78x | 8.88x | 11.58x | 28.66x |
Profitability & Efficiency
V leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
V delivers a 58.9% return on equity — every $100 of shareholder capital generates $59 in annual profit, vs $5 for PROV. HOMB carries lower financial leverage with a 0.22x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), PROV scores 6/9 vs V's 5/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +5.1% | +18.2% | +15.9% | +11.4% | +58.9% |
| ROA (TTM)Return on assets | +0.5% | +2.3% | +1.3% | +2.1% | +22.7% |
| ROICReturn on invested capital | +1.9% | +18.3% | +4.5% | +8.7% | +29.2% |
| ROCEReturn on capital employed | +2.4% | +5.2% | +8.9% | +11.5% | +36.2% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 5 | 6 | 5 |
| Debt / EquityFinancial leverage | 1.66x | — | 2.60x | 0.22x | 0.66x |
| Net DebtTotal debt minus cash | $160M | -$245M | $599.0B | $268M | $5.0B |
| Cash & Equiv.Liquid assets | $53M | $245M | $343.3B | $667M | $20.2B |
| Total DebtShort + long-term debt | $213M | $0 | $942.4B | $935M | $25.2B |
| Interest CoverageEBIT ÷ Interest expense | 0.47x | 1.39x | 0.74x | 1.47x | 26.72x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BSVN five years ago would be worth $28,907 today (with dividends reinvested), compared to $11,816 for PROV. Over the past 12 months, JPM leads with a +21.8% total return vs V's -12.5%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs HOMB's 9.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +8.8% | +13.0% | -0.5% | +2.7% | -6.6% |
| 1-Year ReturnPast 12 months | +14.5% | +20.3% | +21.8% | +3.0% | -12.5% |
| 3-Year ReturnCumulative with dividends | +50.9% | +97.2% | +138.2% | +31.2% | +45.6% |
| 5-Year ReturnCumulative with dividends | +18.2% | +189.1% | +118.2% | +22.1% | +42.0% |
| 10-Year ReturnCumulative with dividends | +25.8% | +169.2% | +465.8% | +57.7% | +330.2% |
| CAGR (3Y)Annualised 3-year return | +14.7% | +25.4% | +33.6% | +9.5% | +13.3% |
Risk & Volatility
PROV leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
PROV is the less volatile stock with a 0.21 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PROV currently trades 98.2% from its 52-week high vs V's 86.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.21x | 0.64x | 0.94x | 0.66x | 0.54x |
| 52-Week HighHighest price in past year | $17.42 | $50.10 | $337.25 | $30.83 | $374.17 |
| 52-Week LowLowest price in past year | $14.95 | $37.56 | $262.71 | $25.50 | $293.89 |
| % of 52W HighCurrent price vs 52-week peak | +98.2% | +92.8% | +95.1% | +91.6% | +86.2% |
| RSI (14)Momentum oscillator 0–100 | 48.8 | 62.6 | 59.1 | 63.7 | 46.9 |
| Avg Volume (50D)Average daily shares traded | 8K | 11K | 7.0M | 1.4M | 6.4M |
Analyst Outlook
Evenly matched — PROV and V each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PROV as "Hold", BSVN as "Buy", JPM as "Buy", HOMB as "Hold", V as "Buy". Consensus price targets imply 22.6% upside for BSVN (target: $57) vs -6.5% for PROV (target: $16). For income investors, PROV offers the higher dividend yield at 3.26% vs V's 0.73%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $16.00 | $57.00 | $339.75 | $31.50 | $368.91 |
| # AnalystsCovering analysts | 10 | 3 | 61 | 19 | 61 |
| Dividend YieldAnnual dividend ÷ price | +3.3% | +2.1% | +1.9% | +2.8% | +0.7% |
| Dividend StreakConsecutive years of raises | 0 | 7 | 15 | 15 | 18 |
| Dividend / ShareAnnual DPS | $0.56 | $0.98 | $5.95 | $0.80 | $2.36 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.1% | +0.3% | +3.9% | +1.5% | +2.2% |
V leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BSVN leads in 1 (Valuation Metrics). 1 tied.
PROV vs BSVN vs JPM vs HOMB vs V: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PROV or BSVN or JPM or HOMB or V a better buy right now?
For growth investors, Visa Inc.
(V) is the stronger pick with 11. 3% revenue growth year-over-year, versus -5. 3% for Home Bancshares, Inc. (HOMB). Bank7 Corp. (BSVN) offers the better valuation at 10. 3x trailing P/E (10. 5x forward), making it the more compelling value choice. Analysts rate Bank7 Corp. (BSVN) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PROV or BSVN or JPM or HOMB or V?
On trailing P/E, Bank7 Corp.
(BSVN) is the cheapest at 10. 3x versus Visa Inc. at 31. 6x. On forward P/E, Bank7 Corp. is actually cheaper at 10. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Bank7 Corp. wins at 0. 61x versus Visa Inc. 's 1. 55x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — PROV or BSVN or JPM or HOMB or V?
Over the past 5 years, Bank7 Corp.
(BSVN) delivered a total return of +189. 1%, compared to +18. 2% for Provident Financial Holdings, Inc. (PROV). Over 10 years, the gap is even starker: JPM returned +465. 8% versus PROV's +25. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PROV or BSVN or JPM or HOMB or V?
By beta (market sensitivity over 5 years), Provident Financial Holdings, Inc.
(PROV) is the lower-risk stock at 0. 21β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately 357% more volatile than PROV relative to the S&P 500. On balance sheet safety, Home Bancshares, Inc. (HOMB) carries a lower debt/equity ratio of 22% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — PROV or BSVN or JPM or HOMB or V?
By revenue growth (latest reported year), Visa Inc.
(V) is pulling ahead at 11. 3% versus -5. 3% for Home Bancshares, Inc. (HOMB). On earnings-per-share growth, the picture is similar: Home Bancshares, Inc. grew EPS 19. 9% year-over-year, compared to -12. 3% for Provident Financial Holdings, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PROV or BSVN or JPM or HOMB or V?
Visa Inc.
(V) is the more profitable company, earning 50. 1% net margin versus 10. 4% for Provident Financial Holdings, Inc. — meaning it keeps 50. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: V leads at 60. 0% versus 14. 8% for PROV. At the gross margin level — before operating expenses — V leads at 80. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PROV or BSVN or JPM or HOMB or V more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Bank7 Corp. (BSVN) is the more undervalued stock at a PEG of 0. 61x versus Visa Inc. 's 1. 55x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Bank7 Corp. (BSVN) trades at 10. 5x forward P/E versus 24. 5x for Visa Inc. — 14. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BSVN: 22. 6% to $57. 00.
08Which pays a better dividend — PROV or BSVN or JPM or HOMB or V?
All stocks in this comparison pay dividends.
Provident Financial Holdings, Inc. (PROV) offers the highest yield at 3. 3%, versus 0. 7% for Visa Inc. (V).
09Is PROV or BSVN or JPM or HOMB or V better for a retirement portfolio?
For long-horizon retirement investors, Provident Financial Holdings, Inc.
(PROV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 21), 3. 3% yield). Both have compounded well over 10 years (PROV: +25. 8%, HOMB: +57. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PROV and BSVN and JPM and HOMB and V?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: PROV is a small-cap income-oriented stock; BSVN is a small-cap deep-value stock; JPM is a large-cap deep-value stock; HOMB is a small-cap deep-value stock; V is a large-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.